cholestyramine resin has been researched along with Disease Exacerbation in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Condoluci, A; Rossi, D | 1 |
| Bose, P; Verstovsek, S | 1 |
| Aarsen, FK; Catsman-Berrevoets, CE; de Wit, MC; Jacobs, BC; Roodbol, J | 1 |
| Brunt, JNH; Chan, DC; Lewis, B; Pang, J; Watts, GF | 1 |
| Battezzati, PM; Crosignani, A; Invernizzi, P; Podda, M; Prina, E; Selmi, C | 1 |
| Inazu, A; Ino, H; Kawashiri, MA; Kobayashi, J; Koizumi, J; Mabuchi, H; Nohara, A; Tada, H; Takata, M; Tsuchida, M; Yamagishi, M | 1 |
| Brown, BG; Gotto, AM; Kolasa, MW; Krasuski, RA; Maranian, AM; Michalek, JE; Monick, E; Personius, BE; Whitney, EJ | 1 |
| Casanada, F; Condorelli, M; D'Armiento, FP; de Nigris, F; Napoli, C; Palinski, W; Silvestre, M; Witztum, JL | 1 |
| Campeau, L; Forman, SA; Forrester, JS; Geller, NL; Gobel, FL; Herd, JA; Hickey, A; Hoogwerf, BJ; Hunninghake, DB; Knatterud, GL; Rosenberg, Y; Terrin, ML; White, CW | 1 |
3 review(s) available for cholestyramine resin and Disease Exacerbation
| Article | Year |
|---|---|
SOHO State of the Art Updates and Next Questions: Clonal Evolution in Chronic Lymphocytic Leukemia.
Topics: Cholestyramine Resin; Clonal Evolution; Disease Progression; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mutation | 2020 |
SOHO State of the Art Updates and Next Questions: Identifying and Treating "Progression" in Myelofibrosis.
Topics: Animals; Cholestyramine Resin; Disease Progression; Humans; Mice; Primary Myelofibrosis; Protein Kinase Inhibitors | 2021 |
Clinical features and management of primary biliary cirrhosis.
Topics: Animals; Autoimmune Diseases; Bone Diseases, Metabolic; Cholagogues and Choleretics; Cholestyramine Resin; Disease Progression; Fatigue; Humans; Hyperlipidemias; Hypertension, Portal; Liver Cirrhosis, Biliary; Liver Transplantation; Malnutrition; Pruritus; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid | 2008 |
3 trial(s) available for cholestyramine resin and Disease Exacerbation
| Article | Year |
|---|---|
Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: Impact of a fat-modified diet and a resin.
Topics: Adult; Aged; Angiography; Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Coronary Artery Disease; Data Interpretation, Statistical; Diet; Disease Progression; Humans; Hyperlipoproteinemia Type II; Incidence; Male; Middle Aged; Phenotype; Severity of Illness Index; Treatment Outcome | 2016 |
A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events.
Topics: Aged; Cholesterol, HDL; Cholestyramine Resin; Coronary Angiography; Coronary Disease; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Exercise Therapy; Female; Gemfibrozil; Humans; Hypolipidemic Agents; Life Style; Male; Middle Aged; Niacin | 2005 |
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial.
Topics: Anticholesteremic Agents; Anticoagulants; Cholesterol, LDL; Cholestyramine Resin; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Follow-Up Studies; Humans; Lipids; Lovastatin; Male; Middle Aged; Postoperative Period; Saphenous Vein; Treatment Outcome | 2001 |
4 other study(ies) available for cholestyramine resin and Disease Exacerbation
| Article | Year |
|---|---|
Long-term outcome of Guillain-Barré syndrome in children.
Topics: Adolescent; Behavioral Symptoms; Child; Child, Preschool; Cholestyramine Resin; Cohort Studies; Cross-Sectional Studies; Disabled Children; Disease Progression; Female; Guillain-Barre Syndrome; Humans; Infant; Infant, Newborn; Male; Netherlands; Neurologic Examination; Quality of Life; Treatment Outcome | 2014 |
Marked aortic valve stenosis progression after receiving long-term aggressive cholesterol-lowering therapy using low-density lipoprotein apheresis in a patient with familial hypercholesterolemia.
Topics: Angina Pectoris; Anticholesteremic Agents; Aortic Valve Stenosis; Blood Component Removal; Cholesterol; Cholestyramine Resin; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Disease Progression; Echocardiography; Female; Heart Valve Prosthesis Implantation; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Middle Aged; Secondary Prevention | 2009 |
Summaries for patients. Targeting cholesterol treatment toward increasing high-density lipoprotein levels.
Topics: Aged; Cholesterol, HDL; Cholestyramine Resin; Coronary Angiography; Coronary Disease; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Exercise Therapy; Female; Gemfibrozil; Humans; Hypolipidemic Agents; Life Style; Male; Middle Aged; Niacin | 2005 |
Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Aorta; Aortic Diseases; Arteriosclerosis; Cholestyramine Resin; Disease Progression; Female; Hypercholesterolemia; Linoleic Acid; Lipid Peroxidation; Malondialdehyde; Pregnancy; Rabbits; Vitamin E | 2001 |